XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 45,731 $ 40,777
Marketable securities 43,339 61,275
Tax incentive receivable 932 946
Prepaid expenses and other current assets 1,420 1,927
Total current assets 91,422 104,925
Tax incentive receivable 581  
Property and equipment, net 479 528
Other assets 132 57
Total assets 92,614 105,510
Current liabilities:    
Accounts payable 3,796 3,020
Accrued expenses 3,661 4,273
Total current liabilities 7,457 7,293
Notes payable, long-term 20,160 20,000
Total liabilities 27,617 27,293
Commitments and contingencies (Note 7)
Stockholders' equity:    
Preferred stock; $0.001 par value per share; 5,000,000 shares authorized as of March 31, 2018 and December 31, 2017; no shares issued and outstanding as of March 31, 2018 and December 31, 2017
Common stock, $0.001 par value per share; 115,000,000 shares authorized as of March 31, 2018 and December 31, 2017; 27,558,883 and 27,489,457 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively 28 27
Additional paid-in capital 370,551 367,825
Accumulated deficit (305,533) (289,577)
Accumulated other comprehensive loss (49) (58)
Total stockholders' equity 64,997 78,217
Total liabilities and stockholders' equity $ 92,614 $ 105,510